RxDoctor Payments Data

Carter Paddock, MD

Procedural Dermatology · Metairie, LANPI 1467541797

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.4% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Sanofi at 34.3% of the total. 2025 is the largest year on record at $1,063, 9.3 times the $114 reported in 2019.

$4,049in general payments, 2019–2025

Across 165 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1K
  • AbbVie$821
  • Johnson & Johnson$654
  • Galderma Laboratories, L.p.$517
  • Biofrontera Inc.$165
  • Sun Pharmaceutical Industries Inc.$126
  • plus $376 from 8 others

What the payments were for

  • Food & beverage$3,78493%
  • Education$2657%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$149,972
Medicare patients
265
Services billed
13,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$44,726
Minocycline Hcl103$1,394
Triamcinolone Acetonide193$1,159
Ketoconazole53$993
Betamethasone Valerate20$985
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip51$943
Mometasone Furoate53$897
ValacyclovirValacyclovir Hcl28$758
Hydrocortisone91$521
Clotrimazole29$380
Clindamycin Phosphate15$299
Minoxidil11$185
Doxycycline Hyclate15$179
Mupirocin14$103
Amoxicillin12$61

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →